Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors

被引：67

作者：

Xin, Zhili ^{[1
]}

Zhao, Hongyu ^{[1
]}

Serby, Michael D. ^{[1
]}

Liu, Bo ^{[1
]}

Liu, Mei ^{[1
]}

Szczepankiewicz, Bruce G. ^{[1
]}

Nelson, Lissa T. J. ^{[1
]}

Smith, Harriet T. ^{[1
]}

Suhar, Tom S. ^{[1
]}

Janis, Rich S. ^{[1
]}

Cao, Ning ^{[1
]}

Camp, Heidi S. ^{[1
]}

Collins, Christine A. ^{[1
]}

Sham, Hing L. ^{[1
]}

Surowy, Teresa K. ^{[1
]}

Liu, Gang ^{[1
]}

机构：

[1] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 15期

关键词：

SCD1; inhibitors; desaturation index;

D O I：

10.1016/j.bmcl.2008.06.088

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of structurally novel stearoyl-CoA desaturase1 (SCD1) inhibitors has been identified via molecular scaffold manipulation. Preliminary structure-activity relationship (SAR) studies led to the discovery of potent, and orally bioavailable piperidine-aryl urea-based SCD1 inhibitors. 4-(2-Chlorophenoxy)-N-[3-(methyl carbamoyl)phenyl]piperidine-1-carboxamide 4c exhibited robust in vivo activity with dose-dependent desaturation index lowering effects. (c) 2008 Elsevier Ltd. All rights reserved.

引用

页码：4298 / 4302

页数：5

共 50 条

[21] Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series
Lachance, Nicolas
Gareau, Yves
Guiral, Sebastien
Huang, Zheng
Isabel, Elise
Leclerc, Jean-Philippe
Leger, Serge
Martins, Evelyn
Nadeau, Christian
Oballa, Renata M.
Ouellet, Stephane G.
Powell, David A.
Ramtohul, Yeeman K.
Tranmer, Geoffrey K.
Trinh, Thao
Wang, Hao
Zhang, Lei
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 980 - 984
[22] Role of Stearoyl-CoA Desaturase 1 in Cardiovascular Physiology
Balatskyi, Volodymyr V.
Dobrzyn, Pawel
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
[23] Discovery of a novel in vivo active heterocyclic inhibitor of stearoyl-CoA desaturase
Voss, M. D.
Zoller, G.
Herling, A. W.
Biemer-Daub, G.
Matter, H.
Pfenninger, A.
Kohlmann, M.
DIABETOLOGIA, 2010, 53
[24] Discovery of 1-(4-phenoxypiperidin-1-yl)-2-arylaminoethanone stearoyl-CoA desaturase 1 inhibitors
Zhao, Hongyu
Serby, Michael D.
Smith, Harriet T.
Cao, Ning
Suhar, Tom S.
Surowy, Teresa K.
Camp, Heidi S.
Collins, Christine A.
Sham, Hing L.
Liu, Gang
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (12) : 3388 - 3391
[25] Stearoyl-CoA Desaturase 1 Activity Is Required for Autophagosome Formation
Ogasawara, Yuta
Itakura, Eisuke
Kono, Nozomu
Mizushima, Noboru
Arai, Hiroyuki
Nara, Atsuki
Mizukami, Tamio
Yamamoto, Akitsugu
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (34) : 23938 - 23950
[26] Discovery of potent and liver-selective stearoyl-CoA desaturase (SCD) inhibitors in an acyclic linker series
Lachance, Nicolas
Guiral, Sebastien
Huang, Zheng
Leclerc, Jean-Philippe
Li, Chun Sing
Oballa, Renata M.
Ramtohul, Yeeman K.
Wang, Hao
Wu, Jin
Zhang, Lei
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 623 - 627
[27] SAR and optimization of thiazole analogs as potent stearoyl-CoA desaturase inhibitors
Ramtohul, Yeeman K.
Black, Cameron
Chan, Chi-Chung
Crane, Sheldon
Guay, Jocelyne
Guiral, Sebastien
Huang, Zheng
Oballa, Renata
Xu, Li-Jing
Zhang, Lei
Li, Chun Sing
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (05) : 1593 - 1597
[28] Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1
Jiang, GQ
Li, ZH
Liu, F
Ellsworth, K
Dallas-Yang, Q
Wu, M
Ronan, J
Esau, C
Murphy, C
Szalkowski, D
Bergeron, R
Doebber, T
Zhang, BB
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (04): : 1030 - 1038
[29] Recent progress in the discovery and development of stearoyl CoA desaturase inhibitors
Uto, Yoshikazu
CHEMISTRY AND PHYSICS OF LIPIDS, 2016, 197 : 3 - 12
[30] Novel biomarker in hepatocellular carcinoma: Stearoyl-CoA desaturase 1
Chen, Yongling
Zhong, Ziqing
Ruan, Xuelian
Zhan, Xiuyu
Ding, Yanting
Wei, Fangyi
Qin, Xue
Yu, Hongli
Lu, Yu
DIGESTIVE AND LIVER DISEASE, 2025, 57 (03) : 770 - 781

← 1 2 3 4 5 →